INTRODUCTION
Ecdysteroids represent a large and diverse family of steroid hormones in nature, with representatives in both insects and plants. They regulate molting and reproduction in arthropods, and play defensive role against herbivores in plants. The most abundant ecdysteroid in nature is 20-hydroxyecdysone (20E, 1), which is also recognized as the major biologically active ecdysteroid, and usually it is accompanied by a large number of minor phytoecdysteroids with lower quantity in plants. More than 480 ecdysteroids have been isolated from plant sources in the past five decades, and ca. one quarter of them have been discovered by the research group of Prof. Báthori at the University of Szeged.
Their structure can be characterized with a steroid skeleton, in which the A/B ring junction is normally cis, while the C/D ring junction is almost always trans. A 7-en-6-one chromophore group can be found in ring B, and a side-chain is usually attached to C-17.
Several hydroxyl groups make these compounds rather polar, and occasionally form glycosidic, ester or ether bonds.
Due to their ability to disrupt hormonal processes in arthropods, ecdysteroids have been investigated to develop safe natural insecticides, however they failed to reach the market for this use. These compounds show extremely low toxicity in mammals, and do not appear to interact with the vertebrate steroid hormone system, still they have been found to exert numerous beneficial effects. Anabolic activity is such an example, and has been investigated in numerous studies, presuming Akt activation as the background of the observed increased protein synthesis. It is suggested that metabolites of 20E (such as poststerone) might be responsible for this activity. Because of the "general strengthening" activity of 20E, it has been marketed all around the world in the form of dietary supplementary products. Wound-healing, antidiabetic, hypocholesterolaemic activities have also been attributed to this compound. 20E is also a good candidate for semi-synthetic transformations, and in a number of studies it has been subjected to chemical modifications to obtain other, less accessible ecdysteroids in larger quantities. Previously, our research group has put a large number of natural ecdysteroids and some of their semi-synthetic derivatives under investigation to observe their effect on multi-drug resistance (MDR) in cancer. Based on these observations, relevant structure-activity relationships (SARs) have been established, which served as a starting point for the hereby presented Ph.D. study.
OBJECTIVES
In search for novel ecdysteroid derivatives as potential modulators of MDR, the following goals were set up: functional ABCB1 efflux pump inhibition; 3) chemo-sensitizing activity in combination with doxorubicin or other chemotherapeutics; and/or 4) effect on Akt-phosphorylation.
Establishing new structure-activity relationships (SARs).
Observing how structural modifications on the tested compounds affect their biological activity related to MDR.
MATERIALS AND METHODS

Starting materials
The starting material, 20E (1, 90% originated from the roots of Cyanotis arachnoidea) was purchased from Shaanxi KingSci Biotechnology Co. Ltd. (Shanghai, China), and further purified by crystallization. Dacryhainansterone (2), 2-deoxy-20-hydroxyecdysone (3), ajugasterone C (4) and polypodine B (5) were previously isolated from Ajuga, Serratula and Silene species.
Preparation of ecdysteroid derivatives
Ecdysteroid dioxolanes (6-28) were obtained from 20E in one step by applying various aldehydes/ketones under acidic conditions -provided by phosphomolybdic acid -in methanol. The reaction mixtures were purified by means of column chromatography (CC), rotational planar chromatography (RPC), reversed-phase high performance liquid chromatography (RP-HPLC), or recrystallization from acetonitrile. Compounds 29-36 were obtained in a similar fashion, but in two consecutive steps, in which a 20,22-monosubstituted ecdysteroid dioxolane was subjected to substitution at the 2,3-diol.
Compounds 37-42 were obtained from 20E by first protecting the more reactive 20,22-diol with phenylboronic acid, which protecting group was later removed by applying H 2 O 2 after dioxolane formation at the 2,3 position. Pure products were obtained by means of RPC.
Base-catalyzed autoxidation of 20E was performed by applying NaOH in aqueous methanol, yielding oxidized ecdysteroid derivatives (43-50) after multiple steps of purification with centrifugal partition chromatography (CPC), CC, preparative thin layer chromatography (prep. TLC) and RP-HPLC. This reaction was also monitored by HPLC in a longitudinal study, and concentrations of compounds were determined at various times.
Compounds 51-55 were obtained by oxidative side-chain cleavage by applying [bis(trifluoroacetoxy)iodo]benzene (PIFA) on corresponding ecdysteroids (1-5, respectively), and means of CPC, RPC and RP-HPLC were used for purification. Poststerone (51) was subjected to dioxolane formation involving the 2,3-diol, yielding compounds 56-64. These reactions were performed by applying p-toluenesulfonic acid as catalyst, and reaction products were purified by RPC and RP-HPLC.
Compound 20 was subjected to fluorination with (diethylamino)sulfur trifluoride (DAST) yielding compounds 65-68, which were further purified by CC and RP-HPLC.
Procedures for structure elucidation
The obtained compounds were characterized and their structures were elucidated by means of different spectroscopic methods (MS, 1D-and 2D-NMR).
Biological evaluation of the compounds
In the experiments on bioactivity, ten human derived cell lines were used (breast does not appear to contribute significantly to the anti-proliferative activity of the compounds. In case of compounds 20 and 65-68, fluorine substitution at C-25 or at C-14 and C-25 had little effect on the very mild anti-proliferative activity of 20, however, presence of a ∆ 14,15 double bond markedly increased the activity. Results are shown on Table 1 and 2). Table 1 -IC50 values of ecdysteroid derivatives (6-36 and 56-68) tested on the parental L5178 and multi-drug resistant L5178MDR cell line, presented as the average of 3 independent experiments ± standard error of the mean (SEM). The dioxolane derivatives (6-36 and 56-68) were also tested for their inhibiting activity on the ABCB1 efflux transporter. Usually, applying higher concentration (20 μM) of the compound led to more potent inhibition, and in some cases resulted in cytotoxicity. It seems that side-chain cleavage does not lead to the appearance of pump inhibition even if it is accompanied by dioxolane formation at C-2,3, as none of the poststerone derivatives (56-64, with the exception of 61) showed any activity in this bioassay, similarly to 20E. In case of compounds 65-68, elimination of 14-OH, as well as fluorination at C-14 or C-25, manifested in a significant increase in the ABCB1 inhibitory activity (see Table 3 ). -position for a stronger activity. Increasing the length of the substituent coupled to C-29 led to a significant increase in activity till the length of three carbon atoms, however, a longer alkyl substituent appeared to be less preferable. Introducing larger aromatic groups did not lead to stronger activities, although further substituents on the aromatic ring were able to increase activity. Addition of a β-methyl group to C-29 could significantly increase the activity as compared to that of the 29α-phenyl substituted derivatives (see Table 4 ). Table 4 -Combination index (CI) values at 50%, 75% and 90% of inhibition at the most active constant ratio of compounds 1, 6-36 and 65-68, combined with doxorubicin on the ABCB1 transfected L5178MDR cell line. 0 < CI <1, CI = 1, CI > 1 represent synergism, additivity and antagonism, respectively. CIavg = (CI50 + 2 x CI75 + 3 x CI90)/6, r represents the linear correlation coefficient of the median-effect plot.
Compounds 37-42 and 56-64 did not show considerable anti-proliferative activity on their own, therefore combination indices (CIs) were not calculated for them. However, they were still tested in combination with doxorubicin. These compounds exerted significant effect in the bioassay, which was even more pronounced in case of the sidechain cleaved poststerone derivatives. Generally, with larger substituents connected to C-2,3, higher activity was observed, which appeared to be most significant in case of an isobutyl group (see Table 5 , results for compounds 37-42 are incomplete and are not listed). Compound 20 could effectively sensitize non-MDR human cell lines with no detectable (MCF7) or very low (LNCaP) expression of the ABCB1 transporter, which supports our assumption that less polar ecdysteroids do not exclusively act as ABCB1 inhibitors.
Compound 6 showed less potent activity than 20, and in most cases, the activity of compound 1 was considered to be irrelevant. Interestingly, however, all three compounds decreased the sensitivity of the cells towards cisplatin (see Table 6 ).
Some dioxolane derivatives (20, 31, 33, 34, 36) -identified as potentially being able to penetrate the blood-brain barrier -were also tested on the SH-SY5Y neuroblastoma cell line towards vincristine. All the tested compounds showed dose-dependent sensitizing activity, and compound 31 proved to be most potent: when applying at 10 μM, it decreased the IC 50 value of vincristine by three orders of magnitude, to as low as 0.056 ± 0.03 nM. This dramatic increase in the observed cytotoxic activity suggests the high sensitivity of this neuroblastoma cell line towards such combinational treatment.
The oxidized ecdysteroid derivatives (43-50, with the exception of 45 and 49) were tested for their capacity to influence the Akt-phosphorylation in C2C12 myotubes.
Compounds 44 and 47 significantly increased Akt-phosphorylation, while compound 48 -the desmotropic pair of 47 -showed the opposite effect at the applied concentration. This puzzling difference between the bioactivities of these isomers is of particular interest for further studies (see Figure 7) .  Our SAR studies on ecdysteroid dioxolanes revealed that they can be engineered to become inactive as functional ABCB1 inhibitors, while retaining a strong chemosensitizing activity with a strong selectivity towards the ABCB1-transfected cancer cells.
 Oxidized ecdysteroid derivatives (43-50) were tested for their activity on the Aktphosphorylation in C2C12 myotubes, and the difference observed between the bioactivities of a desmotropic pair (47 and 48) is of particular interest. To our best knowledge, our work represents the first report of such a phenomenon.
 Further SARs were discovered concerning the anti-proliferative, ABCB1-inhibiting and chemo-sensitizing activity of ecdysteroid dioxolanes (6-42 and 56-68). In general, dioxolane formation and side-chain cleavage increases chemo-sensitizing activity.
 Based on these findings, poststerone dioxolanes (56-64) can be highlighted as the most prospective leads for further research. 
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